Journey Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.15M | Sell |
49,275
-148
| -0.3% | -$27.5K | 0.71% | 32 |
|
|
2025
Q1 | $10.4M | Sell |
49,423
-628
| -1% | -$132K | 0.85% | 28 |
|
|
2024
Q4 | $8.58M | Hold |
50,051
| – | – | 1.03% | 28 |
|
|
2024
Q3 | $8.58M | Hold |
50,051
| – | – | 1.03% | 28 |
|
|
2024
Q2 | $8.58M | Sell |
50,051
-927
| -2% | -$159K | 1.03% | 28 |
|
|
2024
Q1 | $9.28M | Buy |
50,978
+49
| +0.1% | +$8.92K | 1.14% | 24 |
|
|
2023
Q4 | $7.89M | Sell |
50,929
-2,064
| -4% | -$320K | 1.07% | 27 |
|
|
2023
Q3 | $7.9M | Buy |
52,993
+2,071
| +4% | +$309K | 1.18% | 24 |
|
|
2023
Q2 | $6.86M | Sell |
50,922
-11,387
| -18% | -$1.53M | 1.02% | 26 |
|
|
2023
Q1 | $9.93M | Buy |
62,309
+8,579
| +16% | +$1.37M | 1.56% | 17 |
|
|
2022
Q4 | $8.68M | Buy |
53,730
+6,586
| +14% | +$1.06M | 2.16% | 7 |
|
|
2022
Q3 | $6.33M | Buy |
47,144
+2,546
| +6% | +$342K | 1.61% | 12 |
|
|
2022
Q2 | $6.25M | Buy |
44,598
+19,539
| +78% | +$2.74M | 1.44% | 14 |
|
|
2022
Q1 | $4.06M | Buy |
25,059
+3,795
| +18% | +$615K | 1.03% | 22 |
|
|
2021
Q4 | $2.88M | Buy |
21,264
+2,645
| +14% | +$358K | 0.8% | 28 |
|
|
2021
Q3 | $2.01M | Buy |
18,619
+1,713
| +10% | +$185K | 0.65% | 37 |
|
|
2021
Q2 | $1.9M | Buy |
16,906
+1,445
| +9% | +$163K | 0.6% | 47 |
|
|
2021
Q1 | $1.67M | Buy |
15,461
+536
| +4% | +$58K | 0.59% | 50 |
|
|
2020
Q4 | $1.6M | Buy |
+14,925
| New | +$1.6M | 0.6% | 48 |
|